Preclinical HIV vaccine achieves unprecedented success

Researchers report a new HIV vaccine that showed extraordinary effectiveness in preclinical animal studies, eliciting strong immune responses and protection. This breakthrough marks a significant step toward human trials and potentially a viable vaccine against HIV, which continues to affect millions globally. The study's results raise hope for finally controlling the HIV pandemic.

Sources (1)